Aspirin therapy for skin cancer has been suggested by a recent study to reduce the incidence of some skin cancers.

Study researcher, Sigrún Alba Jóhannesdóttir of Aarhus University Hospital in Denmark has found that aspirin and other similar anti-inflammatory painkillers such as ibuprofen and naproxen can lessen the risk of three major types of skin cancer

People who took NSAIDs did not seem to benefit from a reduced risk of developing basal cell carcinoma in general, although they did have a 15 percent and 21 percent reduced risk of developing this type of cancer on less-exposed sites (body areas other than the head and neck) when they took them long term or at high intensity, respectively.

Low incidence of side affects, affordability and availability make aspirin a promising tool in fighting one of the leading cancers.

Sunscreen, reduced time to sun exposure and a diet rich in vitamin A have also been shown to reduce skin cancers.